StockMarketWire.com - Citigroup today downgrades its investment rating on Hikma Pharmaceuticals PLC [LON:HIK] to neutral (from buy).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk